2021 annual financial data
Abeona Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,188.83%.
Operating income was -89,836,000 USD and net income was -84,936,000 USD.
Operating cash flow was -65,665,000 USD.
Get free Abeona Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,000,000 USD
- Operating income
- -89,836,000 USD
- Net income
- -84,936,000 USD
- Operating cash flow
- -65,665,000 USD